FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083686 [Registered on: 28/03/2025] Trial Registered Prospectively
Last Modified On: 24/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Evaluate the utility of VEXUS score as a marker for acute kindey injury in patients of septic shock. 
Scientific Title of Study   Evaluation of VEXUS score as a marker for acute kidney injury in patients of septic shock. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rahul Kumar Sharma 
Designation  DrNB resident 
Affiliation  Department of critical care medicine, Max super-speciality hospital, Saket, New Delhi 
Address  Department of critical care medicine, Max super-speciality hospital, press enclave road, Saket, South, New Delhi. 110017 India

South
DELHI
110017
India 
Phone  9968473703  
Fax    
Email  Dr.rahulsharma1992@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Omender Singh 
Designation  Principal director 
Affiliation  Max super-speciality hospital, Saket, New Delhi  
Address  Department of critical care medicine, Max super-speciality hospital, press enclave road, Saket, South, New Delhi. 110017 India

South
DELHI
110017
India 
Phone  9810734246  
Fax    
Email  Omender.Singh@maxhealthcare.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Omender Singh 
Designation  Principal director 
Affiliation  Max super-speciality hospital, Saket, New Delhi  
Address  Department of critical care medicine, Max super-speciality hospital, press enclave road, Saket, South, New Delhi. 110017 India

South
DELHI
110017
India 
Phone  9810734246  
Fax    
Email  Omender.Singh@maxhealthcare.com  
 
Source of Monetary or Material Support  
Max super-speciality hospital, Saket, New Delhi 
 
Primary Sponsor  
Name  Max superspeciality hospital  
Address  Department of critical care medicine, Max Super-speciality hospital, press enclave road, Saket, South, New Delhi. 110017 India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rahul Kumar Sharma  Max super-speciality Hospital , Saket, New Delhi  Medical ICU 6th floor, Department of critical care medicine, Max super-speciality hospital, press enclave, Saket, South, New Delhi, 110017, INDIA
South
DELHI 
9968473703

Dr.rahulsharma1992@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Max Healthcare Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N178||Other acute kidney failure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  -Patients who fulfil the septic shock definition according to the Sepsis-3 consensus conference.
 
 
ExclusionCriteria 
Details  -Patient’s refusal to participate.
-Patients in which more than 4 hours have elapsed since diagnosis of septic shock.
-Anticipated to undergo immediate surgery.
-Hemodynamic instability due to active haemorrhage.
-Patients with previously known conditions that interfere with Doppler assessments, namely liver cirrhosis.
Pregnancy
Chronic Kidney Disease (CKD) patients on Haemodialysis
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Evaluation of utility of VEXUS score as a marker for acute kidney injury in patients with septic shock.

 
Will be observed till patient is admitted in intensive care unit.

 
 
Secondary Outcome  
Outcome  TimePoints 
1.Correlation of VEXUS score with need of renal replacement therapy in sepsis patients.
2.Correlation of VEXUS score with intensive care unit mortality.
3.Need of renal replacement therapy in sepsis induced acute kidney injury patients.
4.Duration of intensive care unit stay.
 
Will be observed till patient is admitted in intensive care unit. 
 
Target Sample Size   Total Sample Size="82"
Sample Size from India="82" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Septic shock is defined as a subset of sepsis in which particularly profound circulatory, cellular and metabolic abnormalities are associated with greater risk of mortality. Venous congestion is a promising physiological marker that may be able to help direct resuscitation of patients with septic shock. Venous congestion is an important haemodynamic state in sepsis patients because it is associated with impaired organ function, particularly acute kidney injury. Therefore, we intend to evaluate of VEXUS score as a marker for acute kidney injury in patients of septic shock. 
Close